Details for New Drug Application (NDA): 050685
✉ Email this page to a colleague
The generic ingredient in CEDAX is ceftibuten dihydrate. Additional details are available on the ceftibuten dihydrate profile page.
Summary for 050685
Tradename: | CEDAX |
Applicant: | Si Pharms |
Ingredient: | ceftibuten dihydrate |
Patents: | 0 |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 400MG BASE | ||||
Approval Date: | Dec 20, 1995 | TE: | RLD: | No |
Expired US Patents for NDA 050685
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Si Pharms | CEDAX | ceftibuten dihydrate | CAPSULE;ORAL | 050685-002 | Dec 20, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Si Pharms | CEDAX | ceftibuten dihydrate | CAPSULE;ORAL | 050685-002 | Dec 20, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Si Pharms | CEDAX | ceftibuten dihydrate | CAPSULE;ORAL | 050685-002 | Dec 20, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription